Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness
May 7, 2026
Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment
2 min read
False
Advertisement
2026
Roving Reporter Asks: Where Do You See the Most Progress in CGT Manufacturing and Scalability?
May 6, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to explore advances in scaling cell and gene therapies
Pharma Supply Chains in the Crossfire
May 5, 2026
How tariff uncertainty and geopolitical tensions are reshaping pharmaceutical logistics
6 min read
This Week’s Biopharma News: EU Clears First Pertuzumab Biosimilar
May 5, 2026
Plus: NICE backs rozanolixizumab for uncontrolled gMG, Genexine reports SOX2 degrader data, and BeOne secures option on Huahui trispecific antibody
4 min read
What Sponsors Get Wrong When Initiating an Oncology Study
May 4, 2026
How CRO selection significantly influences study outcomes
6 min read
This Week’s CGT News: CRISPR Hits Phase 3 Milestone
May 4, 2026
Intellia’s one-time HAE therapy delivers strong results as Cabaletta strikes CAR-T manufacturing deal
6 min read
Trends and Challenges in Nitrosamine Testing: Part Five – Pharma’s Future
May 1, 2026
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
3 min read
Manufacturing Viral Vectors for the Next Phase of CGT
April 30, 2026
As the sector matures, scalable vector production and robust analytical control are becoming essential to clinical and commercial success
7 min read
Roving Reporter Asks: What Is Your View on the Takeda “U-turn”?
April 29, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to unpack reactions to Takeda’s strategic shift.
This Week’s Biopharma News: Wave of Antibody Approvals
April 28, 2026
FDA expands Tzield, EU clears Dupixent, and Health Canada approves denosumab antibody biosimilars
4 min read
